Chemical Structure (Ravicti 01)
Ravicti Liquid
Product Images NDC 75987-050
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ravicti (NDC 75987-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Horizon Therapeutics Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Ravicti 02)
This appears to be a list of chemical compounds and processes involved in the breakdown of amino acids and lipids. The compounds listed include Glycerol Phenylbutyrate, Glutamate Phenylbutyric Acid, Phenylacetylglutamine, and Glutamine T Phenylacetate. The processes mentioned are Ester Hyarolysis, a-Ketoglutarate Pancreatic Lipases, and Urine Excretion.*
Figure 2 (Ravicti 03)
Figure 3 (Ravicti 04)
Figure 4 (Ravicti 05)
Figure 5 (Ravicti 06)
Principal Display Panel (25 mL Bottle Carton)
This is a medication called RAVICTI, which contains glycerolphenylbutyrate and is an Oral Liquid to be used Only for Oral Use. The medication guide needs to be dispensed to the patient or caregiver. The usual dosage needs to be checked from the Prescribing Information. It is advised to keep the medication out of the reach of children and dispense with a measuring device. The medication needs to be stored at a temperature of 20°-25°C (68°-77°F) and the unused portion needs to be discarded after 28 days of the first opening. This medication is distributed by Horizon Therapeutics USA, Inc., and the country of origin is Austria.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
